Dr. Reddy’s Laboratories is set to attract investor attention after acquiring the India trademarks for specialty brands Progynova® and Cyclo-Progynova® from Mercury Pharma Group Limited for USD 32.15 million. This domestic acquisition significantly strengthens Dr. Reddy’s gynecology portfolio and marks its entry into the Hormone Replacement Therapy segment in India.